Biomind Labs Inc (BMND) — Cash Flow-to-Debt Ratio
Biomind Labs Inc (BMND) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of CA$-48.96K could theoretically repay 0% of its total liabilities (CA$1.74 Million) in one year. See free cash flow generation of Biomind Labs Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biomind Labs Inc Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Biomind Labs Inc across 5 annual periods. Also explore BMND net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Biomind Labs Inc (2021–2025)
Year-by-year debt coverage analysis for Biomind Labs Inc. For market capitalisation and broader financial context, see BMND stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.04x | CA$-67.55K | CA$1.74 Million | ▲ +85.3% |
| 2024 | -0.26x | CA$-354.43K | CA$1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | CA$-765.93K | CA$1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | CA$-2.15 Million | CA$336.72K | ▼ -0.8% |
| 2021 | -6.34x | CA$-2.12 Million | CA$334.95K | — |